In conclusion, our meta-analysis results showed that cinacalcet not only did not reduce all-cause mortality and cardiovascular mortality but increased the risk of adverse events, such as hypocalcemia and gastrointestinal disorders (nausea, vomiting and diarrhea), although it improved serum PTH, calcium and phosphorus levels. This evidence concerns the gene PTH and digestive system disorder.